Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Japan Pharma Sees US Revenues Grow But Policy Impact Still Unclear
Major Firms Report Fiscal Year Results
May 21 2025
•
By
Lisa Takagi
US a key driver of major Japanese pharma companies' growth last fiscal year.
(Shutterstock/AI-generated)
More from Japan
More from Therapy Areas